REFERENCES
- Huston K A, et al. Temporal arteritis: A 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med. 1978; 88(2)162–167
- Brack A, et al. Giant cell vasculitis is a T cell-dependent disease. Mol Med. 1997; 3(8)530–543
- Weyand C M, Bartley G B. Giant cell arteritis: New concepts in pathogenesis and implications for management. Am J Ophthalmol 1997; 123(3)392–395
- Weyand C M, et al. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum. 1997; 40(1)19–26
- McInnes I B, et al. Interleukin 18: A pleiotropic participant in chronic inflammation. Immunol Today. 2000; 21(7)312–315
- Okamura H TH, Kashiwamura S, Yoshimoto T, Nakanishi K. Interleukin-18: A novel cytokine that augments both innate and acquired immunity. Adv Immunol. 1998; 70: 281–312
- Gracie J A, Robertson S E, McInnes I B. Interleukin-18. J Leukoc Biol 2003; 73(2)213–224
- Nordborg E, Nordborg C. Giant cell arteritis: Strategies in diagnosis and treatment. Curr Opin Rheumatol. 2004; 16(1)25–30
- Gonzalez-Gay M A. The diagnosis and management of patients with giant cell arteritis. J Rheumatol 2005; 32(7)1186–1188
- Bongartz T, Matteso E L. Large-vessel involvement in giant cell arteritis. Curr Opin Rheumatol. 2006; 18(1)10–17
- Font C C.M., Coll-Vinent B. Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis. Br J Rheumatol. 1997; 36: 251–254
- Evans J MB.K., Hunder G G. Persistent giant cell arteritis despite corticosteroid treatment. Mayo Clin Proc 1994; 69: 1060–1061
- Pease J E. Asthma, allergy and chemokines. Curr Drug Targets. 2006; 7(1)3–12
- Romagnani P. From basic science to clinical practice: Use of cytokines and chemokines as therapeutic targets in renal diseases. J Nephrol. 2005; 18(3)229–233
- Szekanecz Z, et al. Chemokines in rheumatic diseases. Curr Drug Targets. 2006; 7(1)91–102
- Feldmann M, et al. Future prospects for anti-cytokine treatment. Ann Rheum Dis 2000; 59: i119–i122, Suppl 1
- Okamura H, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995; 378(6552)88–91
- Micallef M J, et al. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: Synergism with interleukin-12 for interferon-gamma production. Eur J Immunol. 1996; 26(7)1647–1651
- Wagner A D, Goronzy J J, Weyand C M. Functional profile of tissue infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease. J Clin Invest 1994; 94(3)1134–1140
- Ma-Krupa W, et al. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med. 2004; 199(2)173–183
- Trinchier G. Interleukin-12 and its role in the generation of TH1 cells. Immunol Today 1993; 14(7)335–338
- Trinchier G. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13: 251–276